FDA Authorizes Pfizer-BioNTech Vaccine for Children 12 to 15 [The New York Times]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: The New York Times
The CoronavirusOutbreakmentContinue reading the main storySupported byF.D.A. Authorizes Pfizer-BioNTech Vaccine for Children 12 to 15The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.Amanda and Ajdin Dropic with their children, from left, Eli, Ty, Lila and Ben. All four children volunteered for Pfizer-BioNTech trials.Credit...Amy Powell for The New York TimesByApoorva MandavilliMay 10, Updated5:43 p.m. ETThe Food and Drug Administration on Monday authorized use of the Pfizer-BioNTech Covid-19 vaccine for 12- to 15-year-olds in the United States, a crucial step in the nation’s steady recovery from the pandemic and a boon to millions of American families eager for a return to normalcy.The authorization caps weeks of anticipation among parents, who have been grappling with how to conduct their s when only the adults in a household are immunized. It removes an obstacle to school reopenings by reducing the threat of transmission i
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- ProSource360 wins opportunity to partner with Pfizer through its Diverse OnDemand Marketplace [Yahoo! Finance]Yahoo! Finance
- Rosy Debuts New Content Focused on Menopause and Migraine EducationPR Web
- If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today [Yahoo! Finance]Yahoo! Finance
- Report: Washington State's $38.8B Life Science Industry Grew 14% from 2020 to 2022 [Yahoo! Finance]Yahoo! Finance
- Global Cytotoxic Drugs Market Size To Exceed USD 27.62 Billion By 2033 | CAGR Of 5.39% [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website